JP2010512333A5 - - Google Patents

Download PDF

Info

Publication number
JP2010512333A5
JP2010512333A5 JP2009540418A JP2009540418A JP2010512333A5 JP 2010512333 A5 JP2010512333 A5 JP 2010512333A5 JP 2009540418 A JP2009540418 A JP 2009540418A JP 2009540418 A JP2009540418 A JP 2009540418A JP 2010512333 A5 JP2010512333 A5 JP 2010512333A5
Authority
JP
Japan
Prior art keywords
type
palonosetron hydrochloride
composition
melting point
palonosetron
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2009540418A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010512333A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/086350 external-priority patent/WO2008073757A1/en
Publication of JP2010512333A publication Critical patent/JP2010512333A/ja
Publication of JP2010512333A5 publication Critical patent/JP2010512333A5/ja
Pending legal-status Critical Current

Links

JP2009540418A 2006-12-07 2007-12-04 塩酸パロノセトロンの結晶及び非晶質形 Pending JP2010512333A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87365606P 2006-12-07 2006-12-07
PCT/US2007/086350 WO2008073757A1 (en) 2006-12-07 2007-12-04 Crystalline and amorphous forms of palonosetron hydrochloride

Publications (2)

Publication Number Publication Date
JP2010512333A JP2010512333A (ja) 2010-04-22
JP2010512333A5 true JP2010512333A5 (enExample) 2010-11-11

Family

ID=39512092

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009540418A Pending JP2010512333A (ja) 2006-12-07 2007-12-04 塩酸パロノセトロンの結晶及び非晶質形

Country Status (4)

Country Link
US (4) US20100105724A1 (enExample)
EP (1) EP2099298A4 (enExample)
JP (1) JP2010512333A (enExample)
WO (1) WO2008073757A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8614225B2 (en) 2006-08-30 2013-12-24 Dr. Reddy's Laboratories Limited Process for the purification of palonosetron or its salt
EP2103612A1 (en) 2006-10-23 2009-09-23 Sicor, Inc. Crystalline forms of palonosetron hydrochloride
EP2099298A4 (en) * 2006-12-07 2010-01-06 Helsinn Healthcare Sa CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE
WO2009087643A1 (en) * 2008-01-11 2009-07-16 Natco Pharma Limited Novel crystalline forms of palonosetron hydrochloride
WO2010056656A2 (en) * 2008-11-11 2010-05-20 Dr. Reddy's Laboratories Ltd. Preparation of crystalline palonosetron hydrochloride
EP2448936A2 (en) 2009-06-30 2012-05-09 Ranbaxy Laboratories Limited Processes for the preparation of form i and form ii of palonosetron hydrochloride
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
CN114315821A (zh) * 2021-12-23 2022-04-12 北大医药股份有限公司 一种盐酸帕洛诺司琼无定形晶型的制备方法
EP4385497A1 (en) 2022-12-12 2024-06-19 Alfred E. Tiefenbacher (GmbH & Co. KG) Antioxidant-free fixed dose combination of netupitant and palonosetron
WO2024126408A1 (en) 2022-12-12 2024-06-20 Alfred E. Tiefenbacher (Gmbh & Co. Kg) Antioxidant-free fixed dose combination of netupitant and palonosetron
IL321446A (en) 2022-12-12 2025-08-01 Tiefenbacher Alfred E Gmbh & Co Kg Fixed-dose combination including netopitant and flunosterone
EP4385500A1 (en) 2022-12-12 2024-06-19 Alfred E. Tiefenbacher (GmbH & Co. KG) Fixed dose combination comprising netupitant and palonosetron

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0430190T3 (da) * 1989-11-28 1995-08-21 Syntex Inc Hidtil ukendte tricykliske forbindelser
US5567818A (en) * 1994-07-08 1996-10-22 Syntex (U.S.A.) Inc. Processes for preparing 2-(1-azabicyclo[2.2.2]oct-3-yl)-1H-benz[de] isoquinolin-1-one derivatives and intermediates useful therein
US5510486A (en) * 1994-07-26 1996-04-23 Syntex (U.S.A.) Inc. Process for preparing 2-(1-azabicyclo 2.2.2!oct-3-yl)-2,3,3A,4,5,6-hexahydro-1H-benz de!isoquinolin-1-one
GB9713730D0 (en) * 1997-06-30 1997-09-03 Ciba Geigy Ag Organic compounds
JP3566105B2 (ja) * 1998-09-14 2004-09-15 財団法人化学技術戦略推進機構 含ヘテロ芳香環スルホニウム塩及び熱硬化性組成物
DE19956786A1 (de) * 1999-11-25 2001-05-31 Basf Ag Verfahren zur Herstellung optisch aktiver Amine
CN1498216A (zh) * 2000-10-30 2004-05-19 ������ҩ��ҵ���޹�˾ 新的奥丹西隆盐酸盐晶体和溶剂化物及其制备方法
US20030051728A1 (en) * 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7064139B2 (en) * 2001-10-29 2006-06-20 Uniroyal Chemical Company, Inc. Method for treating retroviral infections
US20050131045A1 (en) * 2002-04-30 2005-06-16 Judith Aronhime Novel crystal forms of ondansetron, processes for their preparation, pharmaceutical, compositions containing the novel forms and methods for treating nausea using them
JP5690461B2 (ja) * 2002-11-15 2015-03-25 ヘルシン ヘルスケア ソシエテ アノニム 化学療法誘導嘔吐を治療するためのパロノセトロン
CN1768750A (zh) * 2004-11-07 2006-05-10 重庆医药工业研究院有限责任公司 帕洛诺司琼冻干制剂及其制备方法
EP2103612A1 (en) 2006-10-23 2009-09-23 Sicor, Inc. Crystalline forms of palonosetron hydrochloride
EP2099298A4 (en) * 2006-12-07 2010-01-06 Helsinn Healthcare Sa CRYSTALLINE AND AMORPHOUS FORMS OF PALONOSETRON HYDROCHLORIDE

Similar Documents

Publication Publication Date Title
JP2010512333A5 (enExample)
JP2009120624A5 (enExample)
WO2009102155A3 (en) Process for preparation of 2-methyl-2´-phenylpropionic acid derivatives and novel intermediate compounds
JP2009541334A5 (enExample)
JP2009235100A5 (enExample)
JP2012501649A5 (enExample)
JP2004161992A5 (enExample)
JP2004523448A5 (enExample)
JP2012139225A5 (enExample)
NZ597210A (en) Rebaudioside a composition and method for purifying rebaudioside a
WO2010033444A8 (en) Crystalline forms of a 2-thiazolyl- 4-quinolinyl-oxy derivative, a potent hcv inhibitor
WO2011049333A3 (en) Method of preparing zsm-5 zeolite using nanocrystalline zsm-5 seeds
WO2009006297A3 (en) Methods for altering the genome of a monocot plant cell
JP2012132799A5 (enExample)
WO2010104344A3 (en) Process for preparing prostaglandin derivatives
TN2012000435A1 (en) Agomelatine hydrochloride hydrate and preparation thereof
WO2010076810A3 (en) A process for the preparation of gefitinib
JP2009179634A5 (enExample)
WO2010129636A3 (en) Lenalidomide polymorph
TWI455931B (zh) 用於儲存全像術資料的組合物與方法
AR081659A1 (es) Procedimiento de obtencion de la forma cristalina ii del febuxostat
JP2008519878A5 (enExample)
RU2009119567A (ru) Уменьшение избыточной массы тела или ожирения
JP2011511053A5 (enExample)
JP2008173966A5 (enExample)